ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ALTH

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2011/10/25	17:14	Zacks	Zacks #1 Rank Additions for Tuesday - Tale of the Tape	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/10/25	06:21	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/10/25	00:00	Zacks	AMAG/Allos Deal Called Off - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/10/21	22:27	Business Wire	Allos Therapeutics Announces Termination of Merger Agreement with AMAG Pharmaceuticals	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/10/14	19:02	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/10/14	19:02	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/10/14	08:41	Business Wire	Allos Therapeutics Announces Settlement with Putative Class Action Plaintiffs Regarding Merger with AMAG Pharmaceuticals	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/10/13	21:16	Marketwired	Strong Pipelines From Allos Therapeutics and Dynavax Tech Poised to Pay Off	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/10/11	19:09	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/10/11	19:06	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/10/10	21:00	Business Wire	Allos Therapeutics Continues to Work Toward Completion of Merger with AMAG Pharmaceuticals	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/10/01	06:01	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/09/30	19:01	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/09/30	19:01	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/09/24	04:25	Business Wire	Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/09/21	21:02	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/09/21	21:00	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/09/21	19:01	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/09/19	21:16	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/09/17	06:21	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/09/17	05:13	Edgar (US Regulatory)	Amended Current report filing (8-K/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/09/16	06:05	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/08/20	05:30	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/08/20	05:20	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/08/20	05:18	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/08/19	02:16	Zacks	Allos Therapeutics Starts Cancer Study - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/08/17	21:00	Business Wire	Allos Therapeutics Initiates Phase 3 Registration Trial of FOLOTYN® in Newly Diagnosed Patients with Peripheral T-Cell Lymph...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/08/15	17:33	Zacks	Allos Therapeutics Evenly Poised - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/08/10	01:38	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/08/10	01:35	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)